Ezrin mRNA expression level, total protein level, and p-Ezrin(F353) level are reported to contribute to glioma malignant phenotype (Wick et al., 2001; Mao et al., 2014; Liu et al., 2020). This evidence concerns the gene EZR and central nervous system cancer.